Inventor · disambiguated record
Lothar Germeroth
Also filed as: GERMEROTH LOTHAR
9 granted patents·10 pending applications·129 citations·filing 1999–2024
86Inventor score
Files withJUNO THERAPEUTICS GMBH9JUNO THERAPEUTICS INC3UNIV MUENCHEN TECH2GERMEROTH LOTHAR1IBA GMBH1
Top patents by PatentIndex Score
19 records- 0193US9023604B2Method of reversibly staining a target cellSCHMIDT THOMAS·Filed 2012·Granted May 5, 2015·55 cites·20 claims
- 0290US11274278B2Methods, kits and apparatus for expanding a population of cellsJUNO THERAPEUTICS GMBH·Filed 2015·Granted Mar 15, 2022·11 cites·38 claims
- 0384US11913024B2Methods for culturing cells and kits and apparatus for sameJUNO THERAPEUTICS GMBH·Filed 2016·Granted Feb 27, 2024·5 cites·66 claims
- 0484US11466253B2Methods for culturing cells and kits and apparatus for sameJUNO THERAPEUTICS GMBH·Filed 2016·Granted Oct 11, 2022·9 cites·54 claims
- 0572US6515039B1Method for the parallel and combinatory synthesis of compounds bound to a continuous polymeric solid phase supporting materialPOLY AN GMBH·Filed 1999·Granted Feb 4, 2003·49 cites·22 claims
- 0670US2024191188A1Methods for culturing cells and kits and apparatus for sameJUNO THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 0766US2023190952A1Cell surface conjugates and related cell compositions and methodsJUNO THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 0865US2022195388A1Methods, kits and apparatus for expanding a population of cellsJUNO THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 0965US2023295567A1Methods for culturing cells and kits and apparatus for sameJUNO THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 1061US2022229054A1Combination of reversible and irreversible cell labeling for analizing receptor-ligand koff rateUNIV MUENCHEN TECH·Filed 2022·Application pending·0 cites
- 1158US2025090578A1Method of producing a population of immune cells from pluripotent stem cellsREPAIRON IMMUNO GMBH·Filed 2022·Application pending·0 cites
- 1255US11517627B2Cell surface conjugates and related cell compositions and methodsJUNO THERAPEUTICS GMBH·Filed 2018·Granted Dec 6, 2022·0 cites·33 claims
- 1354US12331318B2Non-immunogenic engineered tissue and methods of producing and using the sameGERMEROTH LOTHAR·Filed 2019·Granted Jun 17, 2025·0 cites·13 claims
- 1451US11320431B2Combination of reversible and irreversible cell labeling for analizing receptor-ligand koff rateUNIV MUENCHEN TECH·Filed 2017·Granted May 3, 2022·0 cites·19 claims
- 1550US2023398148A1Cells expressing a chimeric receptor from a modified invariant cd3 immunoglobulin superfamily chain locus and related polynucleotides and methodsJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1648US2024216508A1Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methodsJUNO THERAPEUTICS GMBH·Filed 2021·Application pending·0 cites
- 1745US2023190798A1Cd19-directed chimeric antigen receptor t cell compositions and methods and uses thereofJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1845US2023087953A1Bcma-directed chimeric antigen receptor t cell compositions and methods and uses thereofJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1940US9188589B2Method of reversibly staining a target cellIBA GMBH·Filed 2015·Granted Nov 17, 2015·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Lothar Germeroth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →